[topsearch__bar__shortcode]

December 10, 2024

Rigetti (RGTI) Stock Soars After Successful AI Quantum Achievement

After a successful AI calibration completion was announced, the stock price of Rigetti Computing Inc. (NASDAQ: RGTI) increased significantly. Shares have increased 43.27% to $6.40 as of the most recent check. A Significant Development in Quantum Computing Rigetti Computing (RGTI) reported a significant advancement in the realm of quantum computing in partnership with Quantum Machines. […]

Rigetti (RGTI) Stock Soars After Successful AI Quantum Achievement Read More »

Positive Stock Movement for Cardiff Oncology (CRDF) After Equity Offering

Cardiff Oncology, Inc. (NASDAQ: CRDF) stock is rising remarkably on the US stock charts today. As of the latest check, CRDF shares were up 50.31%, trading at $3.67. This outstanding accomplishment comes after important announcements that showcase the business’s clinical and financial developments. Strategic Equity Offering Cardiff Oncology today revealed that 15,384,619 shares of company

Positive Stock Movement for Cardiff Oncology (CRDF) After Equity Offering Read More »

uniQure (QURE) Stock Soars Amid FDA Approval Milestone

UniQure N.V.’s (NASDAQ: QURE) stock is rising sharply this morning after the company announced a significant milestone in its regulatory licensing course. According to the most recent check, the price of QURE shares jumped 90.54% to $13.90. uniQURE get The FDA’s Approval for AMT-130 The increase in shares is due to UniQure’s successful agreement with

uniQure (QURE) Stock Soars Amid FDA Approval Milestone Read More »

Cumberland (CPIX) Celebrates FDA Nod With Market Rally

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) shares are experiencing a significant boost on the US stock charts today. As of the last check, CPIX stock was on an upsurge of 108.06% to $2.58 following positive regulatory news. Cumberland Achieves Major FDA Approval Cumberland (CPIX) unveiled that a supplementary New Drug Application (sNDA) for its Acetadote product,

Cumberland (CPIX) Celebrates FDA Nod With Market Rally Read More »

Psyence Biomed (PBM) Stock Gains Momentum In Pre-Market

Shares of Psyence Biomedical Ltd. (NASDAQ: PBM) experienced a significant uptick in pre-hour trading, climbing 27.05% to $2.63. This surge follows the announcement of a binding agreement with Optimi Health Corp., marking a pivotal step in Psyence’s global drug development strategy for palliative care applications. Key Agreement Details The newly executed agreement transitions from the

Psyence Biomed (PBM) Stock Gains Momentum In Pre-Market Read More »

Pre-Market Boost For Chimerix (CMRX) As Regulatory Approval Plans Unveiled

Today, Chimerix, Inc. (NASDAQ: CMRX) shares are surging 164.74% in pre-market trade to $2.29, gaining ground on the US stock charts. This positive trend comes after it was revealed that it will apply for fast FDA clearance for its experimental medication, dordaviprone, to treat recurrent H3 K27M-mutant diffuse glioma. New Drug Application Submission Plans Chimerix

Pre-Market Boost For Chimerix (CMRX) As Regulatory Approval Plans Unveiled Read More »